시장보고서

상품코드

1935378

저분자 API 시장 : API 유형별, 용도별, 지역별

Small Molecule API Market, By API Type (Synthetic and Biological), By Application (Oncology, Neurology, Metabolic, Infectious, and Cardiovascular), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

발행일: 2026년 01월 | 리서치사:

Coherent Market Insights | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

저분자 API 시장은 2026년에 1,304억 달러로 추정되며, 2033년까지 1,774억 달러에 달할 것으로 예측됩니다. 2026-2033년에 CAGR 4.5%로 성장할 전망입니다.

리포트 내용		리포트 상세
기준연도 :	2025년	2026년 시장 규모 :	1,304억 달러
과거 데이터 대상 기간 :	2020-2024년	예측 기간 :	2026-2033년
예측 기간인 2026-2033년의 CAGR :	4.50%	2033년의 예측치 :	1,774억 달러

저분자 API는 저분자 분자량의 유기 화합물로서 생물학적 과정의 제어에 기여할 수 있습니다. 대부분의 저분자 화합물은 경구 투여가 가능하며, 체내 흡수율이 높은 임베디드니다. 작은 크기 때문에 빠른 확산성을 가지고 세포내 작용 부위에 도달하는 특성을 가지고 있습니다.

시장 역학

아시아태평양의 저분자 API 제조업체의 확장은 저분자 API 시장의 성장을 이끄는 주요 요인입니다. 예를 들어 BASF는 중국 난징 화학 산업단지내 기존 부지에 새로운 특수 아민 공장 건설을 계획하고 있습니다. 연간 21,000톤의 아민을 생산할 수 있는 이 새로운 다품종 공장은 난징의 특수 아민 복합시설에서 BASF의 아민 제품군을 확장하는 것입니다. 이 공장은 2019년까지 가동될 예정입니다. 또한 저분자 원료의약품 제조업체들은 세계 영업 및 사업개발 부문의 확대에 이어 품질관리, 규제 대응, 프로젝트 관리팀의 인력 보강을 계획하고 있으며, 이는 시장 성장에 긍정적인 영향을 미치고 있습니다.

그러나 원료의약품 제조에 대한 엄격한 규제 정책이 시장 성장을 저해할 수 있습니다. 저분자 원료의약품 제조의 품질 평가, 시설 인증, 신흥 국가공급망 보안 문제 증가에 대한 전 세계의 엄격한 규제 정책은 최종 저분자 원료의약품 제품의 비용에 큰 영향을 미칩니다. 신규 시장 진출기업이 저분자 원료의약품 제조에 진입하고자 할 때, 앞서 언급한 요인으로 인해 재정적 어려움에 직면하고 있습니다.

본 조사의 주요 특징

세계의 저분자 API 시장에 대해 조사 분석했으며, 2025년을 기준 연도로 하여 예측 기간(2026-2033년) 시장 규모(10억 달러)와 연평균 성장률(CAGR)을 조사하여 전해드립니다.
각 부문의 잠재적 매출기회를 확인하고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명합니다.
시장 성장 촉진요인, 저해요인, 억제요인, 기회, 영향 분석, PEST 분석, 제휴/합병/인수, 규제 시나리오, 기술 발전, 저분자 API 제조 공정, 주요 공급업체, 시장 동향에 대한 중요한 정보를 제공합니다.
이 보고서는 기업 개요, 재무 실적, 제품 포트폴리오, 시장 입지, 유통 전략, 주요 개발, 전략, 미래 계획 등 다양한 매개 변수를 기반으로 세계 저분자 API 시장의 주요 업체를 프로파일링합니다.
이 보고서는 마케팅 담당자와 기업 경영진이 향후 제품 출시, 기술 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있도록 돕습니다.
이 세계 저분자 API 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
이해관계자들은 저분자 API 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 쉽게 의사결정을 내릴 수 있습니다.

Report Coverage	Report Details
Base Year:	2025	Market Size in 2026:	USD 130.4 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	4.50%	2033 Value Projection:	USD 177.4 Bn

A small molecule Active Pharmaceutical Ingredient (API) is a low molecular weight organic compound, which may help to control biological process. Most of the small molecules can be administered orally and are most likely to be absorbed by the body. Owing to its small size it has properties of rapid diffusibility to reach the intracellular site of action.

Market Dynamics

Growing expansion of small molecule API manufacturers in the Asia Pacific region is a major factor driving the small molecule API market growth. For instance, BASF is planning to build a new specialty amines plant at its existing site in Nanjing Chemical Industry Park, China. This new multi-product plant will be able to manufacture 21,000 metric tons of amines year, and it extends BASF's amines portfolio at the specialty amines complex in Nanjing. The plant is scheduled to stream by 2019. Moreover the small molecule API manufacturers have planned to add global sales and business development staff, followed by quality, regulatory, and project management teams, which have positively influenced growth of the market.

However, stringent regulatory policies for API manufacturing may hinder the market growth. Stringent global regulatory policies on quality assessments of small molecule API manufacturing, facility certification, and increased supply chain security issues across emerging countries have a large impact on the cost of final small molecule API products. The new entrants willing to enter into small molecule API manufacturing are facing financial challenges, owing to aforementioned factors.

Key features of the study

This report provides in-depth analysis of the small molecule API market and provides market size (USD Bn) and Compound Annual Growth Rate (CAGR %) for the forecast period (2026 - 2033), considering 2025 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, impact analysis, PEST analysis, collaborations, mergers and acquisitions, regulatory scenarios, technological advancements, steps to manufacture small molecule API, major suppliers of small molecule APIs, market trends
It profiles key players in the global small molecule API market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Lonza, Sanofi S.A., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Aesica Pharmaceuticals Ltd., Albemarle Corporation, Cambrex Corporation, BASF SE, Gland Pharma Limited, Gilead Sciences, Inc., AstraZeneca Plc, Baxter International Inc., Boehringer Ingelheim International GmbH, Celgene Corporation, Piramal Pharma Solutions, Recipharm AB, Evonik Industries AG, Glenmark Pharmaceuticals Limited, Siegfried AG, AbbVie Contract Manufacturing, Aurinia Pharmaceuticals Inc., Bayer AG, Patheon, CordenPharma International
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics.
The global small molecule API market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the small molecule API market

Market Segmentation

API Type Insights (Revenue, USD Bn, 2026 - 2033)
- Synthetic
- Biological
Application Insights (Revenue, USD Bn, 2026 - 2033)
- Oncology
- Neurology
- Metabolic
- Infectious
- Cardiovascular
Regional Insights (Revenue, USD Bn, 2026 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- ALLERGAN
- Aurobindo Pharma
- Cambrex Corporation
- Albemarle Corporation
- dr. Reddy's Laboratories Ltd.
- Johnson Matthey
- Siegfried Holding AG
- Pfizer
- Sanofi S.A.
- Novartis AG
- Johnson & Johnson
- Bristol-Myers Squibb
- Bachem Holding AG
- Boehringer Ingelheim GmbH
- Hoffmann-La Roche Ltd
- GlaxoSmithKline PLC
- GILEAD Science Inc.
- Albany Molecular Research Inc.
- Sun Pharmaceuticals
- AstraZeneca
- Merck & Co, Inc.
- BASF SE
- Teva Pharmaceuticals

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By API Type
- Market Snippet, By Application
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- PEST Analysis
- PORTER's Five Forces Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trend

4. Global Small Molecule API Market, By API Type, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Synthetic
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Biological
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

5. Global Small Molecule API Market, By Application, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Oncology
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Neurology
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Metabolic
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Infectious
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Cardiovascular
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

6. Global Small Molecule API Market, By Region, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
North America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By API Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - U.S.
  - Canada
Latin America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By API Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By API Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By API Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By API Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Market Share Analysis, By Country/Region, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country/Region, 2021 - 2033
- Market Size and Forecast, By API Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

7. Competitive Landscape

Heat Map Analysis
Market Share Analysis (3x3 Matrix)
Company Profiles
- ALLERGAN
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Aurobindo Pharma
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Cambrex Corporation
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Albemarle Corporation
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- D.r. Reddy's Laboratories Ltd.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Johnson Matthey
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Siegfried Holding AG
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Pfizer
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Sanofi S.A.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Novartis AG
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Johnson & Johnson
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Bristol-Myers Squibb
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Bachem Holding AG
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Boehringer Ingelheim GmbH
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- F. Hoffmann-La Roche Ltd
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- GlaxoSmithKline PLC
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- GILEAD Science Inc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Albany Molecular Research Inc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Sun Pharmaceuticals
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- AstraZeneca
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Merck & Co, Inc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- BASF SE
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Teva Pharmaceuticals
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates

8. Analyst Recommendation

Wheel of Fortune
Analyst View
Coherent Opportunity Map

9. Section

References
Research Methodology
About Us and Sales Contact

저분자 API 시장 : API 유형별, 용도별, 지역별

Small Molecule API Market, By API Type (Synthetic and Biological), By Application (Oncology, Neurology, Metabolic, Infectious, and Cardiovascular), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

시장 역학

목차

제1장 조사 목적과 전제조건

제2장 시장 범위

제3장 시장 역학, 규제 및 동향 분석

제4장 세계의 저분자 API 시장 : API 유형별, 2026-2033년

제5장 세계의 저분자 API 시장 : 용도별, 2026-2033년

제6장 세계의 저분자 API 원료의약품 시장 : 지역별, 2026-2033년

제7장 경쟁 구도

제8장 애널리스트의 권장사항

제9장 섹션